What's Going On With CVS Health Stock?
What's Going On With CVS Health Stock?
CVS Health Corp (NYSE:CVS) shares are trading marginally lower by 1.52% to $56.97 during Friday's session. The stock has been muted since the company earlier this week reported worse-than-expected second-quarter sales results and cut its FY24 adjusted EPS guidance below estimates.
週五的交易中，CVS Health Corp（紐約證券交易所代碼：CVS）股價小幅下跌1.52％，至56.97美元。自該公司本週早些時候公佈的第二季度銷售業績低於預期並將24財年調整後的每股收益預期下調至低於預期以來，該股一直處於低迷狀態。
What Happened?
發生了什麼？
CVS posted sales of $91.23 billion, slightly below the $91.51 billion consensus, with total revenues up 2.6%, driven by growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments, though offset by a decline in the Health Services segment.
CVS公佈的銷售額爲912.3億美元，略低於預期的915.1億美元，總收入增長2.6％，這得益於其醫療保健福利以及藥房和消費者健康板塊的增長，但被健康服務板塊的下降所抵消。
Adjusted EPS was $1.83, down from $2.21 last year but above the $1.73 consensus. Operating income fell 16.4% to $3.74 billion. The Health Care Benefits segment's revenues grew by 21.4%, while the Health Services segment's revenues dropped by 8.8%.
調整後的每股收益爲1.83美元，低於去年的2.21美元，但高於共識的1.73美元。營業收入下降了16.4％，至37.4億美元。醫療保健福利板塊的收入增長了21.4％，而健康服務板塊的收入下降了8.8％。
Leadership changes were announced, with CEO Karen Lynch taking direct control of the Health Care Benefits segment. CVS revised its 2024 adjusted EPS guidance to $6.40-$6.65, down from at least $7.00, and lowered its cash flow guidance due to continued pressure in the Health Care Benefits segment.
宣佈了領導層變動，首席執行官凱倫·林奇直接控制了醫療保健福利領域。由於醫療福利板塊持續壓力，CVS將其2024年調整後的每股收益預期從至少7.00美元下調至6.40美元至6.65美元，並下調了現金流指導。
Read Also: Boeing's New CEO Kelly Ortberg Shifts Base To Seattle Amid Airplane-Maker's Safety Crisis
另請閱讀：在飛機制造商的安全危機中，波音新任首席執行官凱利·奧特伯格將基地轉移到西雅圖
Is CVS A Good Stock To Buy?
CVS 是一隻值得買入的好股票嗎？
Wall Street analysts view CVS Health on the whole as a Neutral, given the history of coverage over the past three months. Lisa Gill from JP Morgan in CVS Health is the most bearish, expecting a 14.85% fall in the stock in the coming year.
鑑於過去三個月的保險歷史，華爾街分析師將CVS Health總體上視爲中立。摩根大通CVS Health的麗莎·吉爾最爲看跌，預計來年該股將下跌14.85％。
But looking at how the market as a whole thinks of the stock, you can reference historical price action for views on whether investors feel strongly about the stock one way or another. In the past 3 months, CVS Health rose 2.65%, which indicates that opinion improved on the business and how attractive it is to own based on either its stock price, or underlying fundamentals, like revenue, which rose 2.6% over the past year.
但是，從整個市場對股票的看法來看，你可以參考歷史價格走勢，了解投資者是否以某種方式對股票有強烈的看法。在過去的3個月中，CVS Health上漲了2.65％，這表明人們對該業務的看法有所改善，以及根據其股價或收入等基本面（在過去一年中增長了2.6％），擁有該業務的吸引力有所改善。
A complete overview of how Wall Street views individual stocks is available here, while real time updates on the latest analyst actions will be delivered via Benzinga PRO. Try it for free.
華爾街如何看待個股的完整概述可在此處獲得，而分析師最新行動的實時更新將通過Benzinga PRO提供。免費試用。
CVS has a 52-week high of $83.25 and a 52-week low of $52.77.
CVS的52周高點爲83.25美元，52周低點爲52.77美元。